# FDA Inspection 1014399 - Apotex Inc. - June 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/apotex-inc/b73018e8-e186-42c5-8fc6-27ed8d2b5296
Source feed: FDA_Inspections

> FDA Inspection 1014399 for Apotex Inc. on June 14, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014399
- Company Name: Apotex Inc.
- Inspection Date: 2017-06-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1269753 - 2025-07-31](https://www.keypedia.com/records/fda_inspections/apotex-inc/97a6f469-c215-4e98-989c-8fcd9419767a)
- [FDA Inspection 1269753 - 2025-07-31](https://www.keypedia.com/records/fda_inspections/apotex-inc/57bde052-03fc-40c8-847d-4328a318e47b)
- [FDA Inspection 1187415 - 2022-09-23](https://www.keypedia.com/records/fda_inspections/apotex-inc/165e170e-ceda-479d-af49-04af908c89f0)
- [FDA Inspection 1096465 - 2019-06-19](https://www.keypedia.com/records/fda_inspections/apotex-inc/ed904b8d-eb59-4fe1-a5a8-7cc66e9c7e02)
- [FDA Inspection 1055197 - 2018-05-10](https://www.keypedia.com/records/fda_inspections/apotex-inc/71cde42d-9f01-4c81-a7fa-462e94b2420a)

Company: https://www.keypedia.com/companies/apotex-inc/014ba53e-d2d8-4cf9-9b1f-ae5074083865

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c